<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hurt at Job Lawyer &#124; Injured at Work Attorneys</title>
	<atom:link href="http://hurtatjob.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://hurtatjob.com</link>
	<description></description>
	<lastBuildDate>Sat, 19 May 2012 15:29:52 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Clinical data from Boston Scientific endoscopy studies to be presented at DDW</title>
		<link>http://hurtatjob.com/2012/05/19/clinical-data-from-boston-scientific-endoscopy-studies-to-be-presented-at-ddw/</link>
		<comments>http://hurtatjob.com/2012/05/19/clinical-data-from-boston-scientific-endoscopy-studies-to-be-presented-at-ddw/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=ae4f72e83858d4a533bccbc2d04fca21</guid>
		<description><![CDATA[Boston Scientific Corporation announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week (DDW), May 19 – 22 in San Diego. ]]></description>
			<content:encoded><![CDATA[Boston Scientific Corporation announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week (DDW), May 19 – 22 in San Diego. ]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/clinical-data-from-boston-scientific-endoscopy-studies-to-be-presented-at-ddw/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care</title>
		<link>http://hurtatjob.com/2012/05/19/lkcf-spirit-of-women%e2%80%99s-heartcaring-to-help-reduce-disparities-in-diagnosis-and-care-2/</link>
		<comments>http://hurtatjob.com/2012/05/19/lkcf-spirit-of-women%e2%80%99s-heartcaring-to-help-reduce-disparities-in-diagnosis-and-care-2/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=bc775c7c2d95a1355d43e7230be18a47</guid>
		<description><![CDATA[In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in th...]]></description>
			<content:encoded><![CDATA[In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in the diagnostics, clinical care, and survival rate of heart ...]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/lkcf-spirit-of-women%e2%80%99s-heartcaring-to-help-reduce-disparities-in-diagnosis-and-care-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care</title>
		<link>http://hurtatjob.com/2012/05/19/lkcf-spirit-of-women%e2%80%99s-heartcaring-to-help-reduce-disparities-in-diagnosis-and-care/</link>
		<comments>http://hurtatjob.com/2012/05/19/lkcf-spirit-of-women%e2%80%99s-heartcaring-to-help-reduce-disparities-in-diagnosis-and-care/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=4ab0144754dee0a921626a51233ca25a</guid>
		<description><![CDATA[In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in th...]]></description>
			<content:encoded><![CDATA[In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in the diagnostics, clinical care, and survival rate of heart ...]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/lkcf-spirit-of-women%e2%80%99s-heartcaring-to-help-reduce-disparities-in-diagnosis-and-care/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quest Diagnostics introduces four new tests panels for CAH</title>
		<link>http://hurtatjob.com/2012/05/19/quest-diagnostics-introduces-four-new-tests-panels-for-cah-2/</link>
		<comments>http://hurtatjob.com/2012/05/19/quest-diagnostics-introduces-four-new-tests-panels-for-cah-2/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=1711c3a2bfdd633ed7bc1d88a0dc6400</guid>
		<description><![CDATA[Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder ...]]></description>
			<content:encoded><![CDATA[Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women. ]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/quest-diagnostics-introduces-four-new-tests-panels-for-cah-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quest Diagnostics introduces four new tests panels for CAH</title>
		<link>http://hurtatjob.com/2012/05/19/quest-diagnostics-introduces-four-new-tests-panels-for-cah/</link>
		<comments>http://hurtatjob.com/2012/05/19/quest-diagnostics-introduces-four-new-tests-panels-for-cah/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=08bd45b8ec321553eddb9366cc6cb5c1</guid>
		<description><![CDATA[Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder ...]]></description>
			<content:encoded><![CDATA[Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women. ]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/quest-diagnostics-introduces-four-new-tests-panels-for-cah/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ceregene announces new data from CERE-120 clinical trial on Parkinson’s</title>
		<link>http://hurtatjob.com/2012/05/19/ceregene-announces-new-data-from-cere-120-clinical-trial-on-parkinson%e2%80%99s-2/</link>
		<comments>http://hurtatjob.com/2012/05/19/ceregene-announces-new-data-from-cere-120-clinical-trial-on-parkinson%e2%80%99s-2/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=07fe32d87ce8c67434a49e39ee2c1988</guid>
		<description><![CDATA[Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivere...]]></description>
			<content:encoded><![CDATA[Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivered to the degenerating dopamine nerves in patients with Parkinson's disease following treatment with CERE-120. ]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/ceregene-announces-new-data-from-cere-120-clinical-trial-on-parkinson%e2%80%99s-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ceregene announces new data from CERE-120 clinical trial on Parkinson’s</title>
		<link>http://hurtatjob.com/2012/05/19/ceregene-announces-new-data-from-cere-120-clinical-trial-on-parkinson%e2%80%99s/</link>
		<comments>http://hurtatjob.com/2012/05/19/ceregene-announces-new-data-from-cere-120-clinical-trial-on-parkinson%e2%80%99s/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=cf156d24a3e12e9673739382c77e673b</guid>
		<description><![CDATA[Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivere...]]></description>
			<content:encoded><![CDATA[Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivered to the degenerating dopamine nerves in patients with Parkinson's disease following treatment with CERE-120. ]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/ceregene-announces-new-data-from-cere-120-clinical-trial-on-parkinson%e2%80%99s/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Receptos to present scientific podium presentation about RPC1063 at DDW 2012</title>
		<link>http://hurtatjob.com/2012/05/19/receptos-to-present-scientific-podium-presentation-about-rpc1063-at-ddw-2012-2/</link>
		<comments>http://hurtatjob.com/2012/05/19/receptos-to-present-scientific-podium-presentation-about-rpc1063-at-ddw-2012-2/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=95f2fd4827d76d72e0f34e9588058237</guid>
		<description><![CDATA[Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, C...]]></description>
			<content:encoded><![CDATA[Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, California. DDW attracts thousands of physicians, researchers, and academics ...]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/receptos-to-present-scientific-podium-presentation-about-rpc1063-at-ddw-2012-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Receptos to present scientific podium presentation about RPC1063 at DDW 2012</title>
		<link>http://hurtatjob.com/2012/05/19/receptos-to-present-scientific-podium-presentation-about-rpc1063-at-ddw-2012/</link>
		<comments>http://hurtatjob.com/2012/05/19/receptos-to-present-scientific-podium-presentation-about-rpc1063-at-ddw-2012/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:52 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=4abd1059c67203f28c7a069a18c184ef</guid>
		<description><![CDATA[Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, C...]]></description>
			<content:encoded><![CDATA[Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, California. DDW attracts thousands of physicians, researchers, and academics ...]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/receptos-to-present-scientific-podium-presentation-about-rpc1063-at-ddw-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Santarus to present UCERIS Phase III trial data on ulcerative colitis at DDW meeting</title>
		<link>http://hurtatjob.com/2012/05/19/santarus-to-present-uceris-phase-iii-trial-data-on-ulcerative-colitis-at-ddw-meeting/</link>
		<comments>http://hurtatjob.com/2012/05/19/santarus-to-present-uceris-phase-iii-trial-data-on-ulcerative-colitis-at-ddw-meeting/#comments</comments>
		<pubDate>Sat, 19 May 2012 15:29:51 +0000</pubDate>
		<dc:creator>Houston Mesothelioma Attorney</dc:creator>
		
		<guid isPermaLink="false">http://hurtatjob.com/?guid=31afcfa1a8eab20368ad21521528f84a</guid>
		<description><![CDATA[Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonide) 6 mg tablets will be featured in four poster pres...]]></description>
			<content:encoded><![CDATA[Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonide) 6 mg tablets will be featured in four poster presentations at the Digestive Disease Week (DDW) Meeting being held at the San Diego ...]]></content:encoded>
			<wfw:commentRss>http://hurtatjob.com/2012/05/19/santarus-to-present-uceris-phase-iii-trial-data-on-ulcerative-colitis-at-ddw-meeting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

